Vaso Corporation Announces Financial Results for Fourth Quarter and Full Year 2024
The Company Reports Continued Growth in Annual RevenuePLAINVIEW, N.Y., March 31, 2025 (GLOBE NEWSWIRE) -- Vaso Corporation (“Vaso”) (OTCQX: VASO),...
Diagnostics
Intelligent Bio Solutions Expands Middle East Market Reach with Arabic Integration in Drug Screening System
Integration of Arabic opens opportunities in the Middle East and supports Company’s strategic global expansion goals Drug Screening Reader -...
Reaffirming Leadership: Medit’s Strong Presence at IDS 2025
COLOGNE, Germany and SEOUL, South Korea, March 31, 2025 /PRNewswire/ -- Medit, a global leader in digital dentistry solutions, made...
GE HealthCare Completes Acquisition of Nihon Medi-Physics (NMP), a Leading Radiopharmaceutical Company in Japan
GE HealthCare has completed its acquisition of Sumitomo Chemical’s 50% stake in Nihon Medi-Physics (NMP), giving it full ownership. As...
Castle Biosciences’ DecisionDx®-SCC Data Earns Top Five Abstract at NCCN 2025, Shows Significantly Enhanced Risk Stratification Beyond Current Staging Within NCCN Risk Groups
New, combined validation cohort of 1,412 patients with high-risk squamous cell carcinoma (SCC) demonstrates that the addition of DecisionDx-SCC to...
Antithrombin Blood Test from Siemens Healthineers Now FDA Cleared as a Companion Diagnostic for Qfitlia, a Sanofi Hemophilia Therapy
The assay now can measure antithrombin (AT) activity levels for people treated with Qfitlia Measuring AT activity levels helps people...
GE HealthCare unveils Revolution™ Vibe CT system with Unlimited One-Beat Cardiac imaging and AI Solutions
GE HealthCare’s Revolution Vibe CTi enables more facilities to elevate patient care by offering advanced cardiac imaging technology that helps...
Curium Completes the Acquisition of Monrol as Part of its Plan to Significantly Expand Lutetium-177 Capacity and PET Footprint
Positions Curium as leading manufacturer of Lu-177 isotopeBrings innovative R&D expertise and pipeline to Curium Enhances Curium’s SPECT & PET...
Spectral AI Announces 2024 Fourth Quarter and Full Year Financial Results
2024 Research & Development Revenue of $30 Million Successful Results from the US Burn Validation Study On Track for Regulatory...
Single-cell Analysis Market Surges to USD 5.4 Billion by 2033, Propelled by 9.5% CAGR – Verified Market Reports®
The Single-Cell Analysis Market is experiencing robust expansion, driven by surging demand for precision medicine, advancements in genomics, and rising investments...
Oragenics, Inc. Provides Q1 2025 Shareholder Update on Strategic and Financial Progress
ONP-002 Advances Toward Phase IIa Concussion Trial with Strengthened Financial Foundation and Industry MomentumSARASOTA, Fla., March 27, 2025 (GLOBE NEWSWIRE)...
ProPhase Labs Inc. to Present 2024 Year End Financial Results on March 31, 2025
GARDEN CITY, NY, March 27, 2025 (GLOBE NEWSWIRE) -- ProPhase Labs Inc. (NASDAQ: PRPH), (the “Company” or “ProPhase”), a next...
Chan Zuckerberg Initiative Announces New Biohub to Develop Breakthrough Imaging Technologies to Observe Cells in Action
The CZ Biohub San Francisco and CZ Imaging Institute will join together to develop novel imaging technologies that provide entirely...
Ascential Medical & Life Sciences Announces Executive Leadership Changes to Drive Strategic Growth
Ellen Scipta and Chris Cowen join the organization as CFO and CCO, respectively, while Todd Martensen transitions from CCO to...
Medrio Enhances RTSM For Faster Clinical Trial Starts and Greater Flexibility
SAN FRANCISCO, March 26, 2025 /PRNewswire/ -- Medrio, a global leader in clinical trial technology, today announced enhancements to its randomization...
Lunit to Present AI Study on EGFR Mutation Prediction in NSCLC at AACR 2025 in Collaboration with AstraZeneca
AI-powered model predicts EGFR mutations from H&E-stained slides, demonstrating robust performance across diverse clinical settings and helping overcome barriers to...
Rarecells Inc. Appoints Dr. Neil Kurtz to Board of Directors
NEW YORK and PARIS, March 26, 2025 /PRNewswire/ -- Rarecells Inc., a pioneering company in liquid biopsy technology, is pleased...
Paving the Way for Early Esophageal Cancer Detection:
New Sampling Technique Further Optimizes WATS3D Test Quality SUFFERN, N.Y., March 25, 2025 /PRNewswire/ -- CDx Diagnostics today announced that in...
Belay Diagnostics Partners with GenomOncology to Support High-Performance Liquid Biopsy Test for Central Nervous System Cancer Detection
CLEVELAND, March 25, 2025 /PRNewswire/ -- Belay Diagnostics announces its partnership with GenomOncology (GO), a precision medicine software company that provides...
University of Florida Adopts ScribbleVet AI Scribe Tools for Veterinary Facilities, Students
LOS ANGELES and GAINESVILLE, Fla., March 25, 2025 /PRNewswire/ -- ScribbleVet, an AI-powered scribe used by thousands of veterinarians, and...